ChemDAQ Partners with AHS to Expand Access to Continuous Chemical Vapor Monitoring Across Canadian Healthcare
ChemDAQ has formed a partnership with Associated Health Systems Inc. (AHS) to enhance access to continuous monitoring of hazardous chemical vapors in Canadian healthcare facilities. This collaboration will provide hospital medical device reprocessing departments with real-time information about chemical exposure risks, particularly concerning hydrogen peroxide, peracetic acid, and ethylene oxide. The partnership will be showcased at the CAMDR 2026 conference in St. John’s, Newfoundland & Labrador, where discussions will focus on safety measures for staff exposed to chemical sterilants.
Partnership to Be Showcased at Canadian Association of Medical Device Reprocessing (CAMDR) 2026 in St. John’s, Newfoundland & Labrador PITTSBURGH, Sept. 30, 2026 /PRNewswire/ — ChemDAQ, a leading provider of hazardous gas monitoring solutions, is pleased to announce a new partnership…